At Glenmark, we look at global healthcare leadership as a responsibility. A responsibility to formulate new ways to safeguard health in a new world. To go from treating illness to also anticipating future health needs. From countering problems to also fostering resilience. From extending lifespans to also building healthier futures.

These demands inspire us to drive differentiated innovation to deliver novel therapies, while also expanding accessibility to high-quality medicines for patients around the globe.

Over the years, we have developed deep therapeutic expertise across the focus areas of Oncology, Dermatology, and Respiratory. This expertise manifests in the form of a multi-tiered product portfolio that includes branded, specialty, generics and consumer.

The depth of our expertise is complemented by the width of our presence, with four cutting-edge R&D centres, eleven world-class manufacturing sites, and an established commercial presence across India, the U.S., Europe, Latin America, Asia Pacific, the Middle East 
and Africa.

This unique combination of deep scientific expertise and wide commercial reach position us perfectly to deliver differentiated, accessible, and globally relevant therapies on a 
consistent basis.